Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Energy Industry News Superior Plus to acquire Certarus to form major lower carbon fuels platform Superior Plus will acquire Certarus, a North American low carbon energy solutions provider, for CAD 1.05bn ($770 million)… byRaghuram KadariDecember 31, 2022